Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
dc.contributor.author | Stratmann, Svea | |
dc.contributor.author | Yones, Sara A. | |
dc.contributor.author | Mayrhofer, Markus | |
dc.contributor.author | Norgren, Nina | |
dc.contributor.author | Skaftason, Aron | |
dc.contributor.author | Sun, Jitong | |
dc.contributor.author | Smolińska, Karolina | |
dc.contributor.author | Komorowski, Jan | |
dc.contributor.author | Herlin, Morten Krogh | |
dc.contributor.author | Sundström, Christer | |
dc.contributor.author | Eriksson, Anna | |
dc.contributor.author | Höglund, Martin | |
dc.contributor.author | Palle, Josefine | |
dc.contributor.author | Abrahamsson, Jonas | |
dc.contributor.author | Jahnukainen, Kirsi | |
dc.contributor.author | Munthe-Kaas, Monica Cheng | |
dc.contributor.author | Zeller, Bernward | |
dc.contributor.author | Tamm, Katja Pokrovskaja | |
dc.contributor.author | Cavelier, Lucia | |
dc.contributor.author | Holmfeldt, Linda | |
dc.date.accessioned | 2022-01-31T09:19:36Z | |
dc.date.available | 2022-01-31T09:19:36Z | |
dc.date.created | 2022-01-19T11:57:56Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Blood Advances. 2021, 5 (3), 900-912. | |
dc.identifier.issn | 2473-9529 | |
dc.identifier.uri | https://hdl.handle.net/11250/2975850 | |
dc.language.iso | eng | |
dc.title | Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 900-912 | |
dc.source.volume | 5 | |
dc.source.journal | Blood Advances | |
dc.source.issue | 3 | |
dc.identifier.doi | 10.1182/bloodadvances.2020003709 | |
dc.identifier.cristin | 1984591 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 |
Files in this item
This item appears in the following Collection(s)
-
Artikler [5061]
-
Publikasjoner fra CRIStin FHI [7531]